Financhill
Buy
59

RGLS Quote, Financials, Valuation and Earnings

Last price:
$7.94
Seasonality move :
-22.76%
Day range:
$7.92 - $7.97
52-week range:
$0.83 - $8.20
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
7.96x
Volume:
819.4K
Avg. volume:
2.3M
1-year change:
272.77%
Market cap:
$549.7M
Revenue:
--
EPS (TTM):
-$0.73

Regulus Therapeutics SEC Filings

Company Filed Form Type Description
RGLS
Regulus Therapeutics
05/09/2024 10-Q 10-Q filing on 05/09/2024 View Form
RGLS
Regulus Therapeutics
11/09/2023 10-Q 10-Q filing on 11/09/2023 View Form
RGLS
Regulus Therapeutics
08/08/2023 10-Q 10-Q filing on 08/08/2023 View Form
RGLS
Regulus Therapeutics
05/11/2023 10-Q 10-Q filing on 05/11/2023 View Form
RGLS
Regulus Therapeutics
11/14/2022 10-Q 10-Q filing on 11/14/2022 View Form
RGLS
Regulus Therapeutics
08/11/2022 10-Q 10-Q filing on 08/11/2022 View Form
RGLS
Regulus Therapeutics
05/13/2022 10-Q 10-Q filing on 05/13/2022 View Form
RGLS
Regulus Therapeutics
11/12/2021 10-Q 10-Q filing on 11/12/2021 View Form
RGLS
Regulus Therapeutics
08/10/2021 10-Q 10-Q filing on 08/10/2021 View Form
RGLS
Regulus Therapeutics
05/14/2021 10-Q 10-Q filing on 05/14/2021 View Form
RGLS
Regulus Therapeutics
11/05/2020 10-Q 10-Q filing on 11/05/2020 View Form
RGLS
Regulus Therapeutics
08/13/2020 10-Q 10-Q filing on 08/13/2020 View Form
RGLS
Regulus Therapeutics
05/14/2020 10-Q 10-Q filing on 05/14/2020 View Form
RGLS
Regulus Therapeutics
03/12/2020 10-K 10-K filing on 03/12/2020 View Form
RGLS
Regulus Therapeutics
11/12/2019 10-Q 10-Q filing on 11/12/2019 View Form
RGLS
Regulus Therapeutics
08/08/2019 10-Q 10-Q filing on 08/08/2019 View Form
RGLS
Regulus Therapeutics
05/10/2019 10-Q 10-Q filing on 05/10/2019 View Form
RGLS
Regulus Therapeutics
04/29/2019 10-K 10-K filing on 04/29/2019 View Form
RGLS
Regulus Therapeutics
03/18/2019 10-K 10-K filing on 03/18/2019 View Form
RGLS
Regulus Therapeutics
11/09/2018 10-Q 10-Q filing on 11/09/2018 View Form
RGLS
Regulus Therapeutics
08/09/2018 10-Q 10-Q filing on 08/09/2018 View Form
RGLS
Regulus Therapeutics
05/10/2018 10-Q 10-Q filing on 05/10/2018 View Form
RGLS
Regulus Therapeutics
03/08/2018 10-K 10-K filing on 03/08/2018 View Form
RGLS
Regulus Therapeutics
11/08/2017 10-Q 10-Q filing on 11/08/2017 View Form
RGLS
Regulus Therapeutics
08/02/2017 10-Q 10-Q filing on 08/02/2017 View Form
RGLS
Regulus Therapeutics
05/05/2017 10-Q 10-Q filing on 05/05/2017 View Form
RGLS
Regulus Therapeutics
03/03/2017 10-K 10-K filing on 03/03/2017 View Form
RGLS
Regulus Therapeutics
11/02/2016 10-Q 10-Q filing on 11/02/2016 View Form
RGLS
Regulus Therapeutics
08/03/2016 10-Q 10-Q filing on 08/03/2016 View Form
RGLS
Regulus Therapeutics
05/03/2016 10-Q 10-Q filing on 05/03/2016 View Form
RGLS
Regulus Therapeutics
02/23/2016 10-K 10-K filing on 02/23/2016 View Form
RGLS
Regulus Therapeutics
11/06/2015 10-Q 10-Q filing on 11/06/2015 View Form
RGLS
Regulus Therapeutics
08/05/2015 10-Q 10-Q filing on 08/05/2015 View Form

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will Asana Stock Be in 5 Years?
Where Will Asana Stock Be in 5 Years?

Asana stock hasn’t given many investors on Wall Street any…

Where Will Dell Stock Be in 5 Years?
Where Will Dell Stock Be in 5 Years?

So you’re looking at Dell (NASDAQ: DELL) and wondering, “Is…

Where Will Cameco Stock Be in 5 Years?
Where Will Cameco Stock Be in 5 Years?

Cameco (NYSE: CCJ) isn’t exactly the kind of stock you…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
70
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 47x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
84
SBET alert for May 30

SharpLink Gaming [SBET] is down 3.17% over the past day.

Buy
55
RGC alert for May 30

Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.

Buy
73
CTEV alert for May 30

Claritev [CTEV] is up 7.82% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock